Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 84,512 | 415,484 | 93,855 | 291,342 | 186,986 |
| Cost of Goods | 60,619 | 46,242 | 59,209 | 154,976 | 98,929 |
| Gross Profit | 23,893 | 369,242 | 34,646 | 136,366 | 88,057 |
| Operating Expenses | 158,530 | 208,486 | 179,686 | 320,910 | 214,618 |
| Operating Income | -134,018 | 160,998 | -144,831 | -183,568 | -125,632 |
| Interest Expense | 4,236 | 4,143 | 4,111 | 4,117 | 2,859 |
| Other Income | 15,922 | 7,731 | 3,654 | 10,984 | -2,982 |
| Pre-tax Income | -122,332 | 164,586 | -145,288 | -176,701 | -131,473 |
| Income Tax | -1,032 | 2,205 | 2,262 | 1,688 | -697 |
| Net Income Continuous | -121,300 | 162,381 | -147,550 | -178,389 | -130,776 |
| Net Income | $-121,300 | $162,381 | $-147,550 | $-178,389 | $-130,776 |
| EPS Basic Total Ops | -0.76 | 1.09 | -1.05 | -1.39 | -1.26 |
| EPS Basic Continuous Ops | -0.76 | 1.09 | -1.05 | -1.38 | -1.26 |
| EPS Diluted Total Ops | -0.76 | 0.99 | -1.05 | -1.32 | -1.26 |
| EPS Diluted Continuous Ops | -0.76 | 0.98 | -1.05 | -1.29 | -1.26 |
| EPS Diluted Before Non-Recurring Items | -0.76 | 0.99 | -1.05 | N/A | N/A |
| EBITDA(a) | $-121,318 | $172,130 | $-132,684 | $-172,774 | $-114,311 |